 | Issue navigator |
| |
Journal of the International AIDS Society publishes selected research, proceedings and collections of thematic reviews as supplements. All articles published in supplements are subject to peer review and are free to access online. The journal also publishes supplements containing meeting abstracts.
Contents of Volume 11 Suppl 1
Abstracts of the Ninth International Congress on Drug Therapy in HIV Infection
Meeting abstracts A single PDF containing all abstracts in this Supplement is available here.
from Ninth International Congress on Drug Therapy in HIV Infection
Glasgow, UK. 9  13 November 2008
| Keynote presentation
 Pathogenesis of HIV infection: implications for treatment and prevention HC Lane Journal of the International AIDS Society 2008, 11(Suppl 1):K1 (10 November 2008) [Abstract] [Full text] [PDF] [PubMed] [Related articles] Keynote presentation
 How will we use the new ART drugs? C Katlama Journal of the International AIDS Society 2008, 11(Suppl 1):K2 (10 November 2008) [Abstract] [Full text] [PDF] Keynote presentation
 The implications beyond public health if we don't manage the HIV epidemic A Whiteside Journal of the International AIDS Society 2008, 11(Suppl 1):K3 (10 November 2008) [Abstract] [Full text] [PDF] Oral presentation
 O111 Global impact of HIV drug resistance D Pillay Journal of the International AIDS Society 2008, 11(Suppl 1):O1 (10 November 2008) [Abstract] [Full text] [PDF] Oral presentation
 O112 Trends in transmitted HIV drug resistance among non-B subtypes in the UK D Chilton, L Harrison, H Green, S Lattimore, V Delpech, D Pillay Journal of the International AIDS Society 2008, 11(Suppl 1):O2 (10 November 2008) [Abstract] [Full text] [PDF] Oral presentation
 O113 HIV-1 clade C resistance genotypes after first virological failure in a large community ART programme C Orrell, RP Walensky, E Losina, KA Freedberg, R Wood Journal of the International AIDS Society 2008, 11(Suppl 1):O3 (10 November 2008) [Abstract] [Full text] [PDF] Oral presentation
 O114 NNRTI mutations are efficiently transmitted within clusters of new HIV infections BG Brenner, T d'Aquin Toni, M Roger, JP Routy, D Moisi, MA Wainberg Journal of the International AIDS Society 2008, 11(Suppl 1):O4 (10 November 2008) [Abstract] [Full text] [PDF] Oral presentation
 O115 Importance of detecting minority variants in the clinical management of HIV D Kuritzkes Journal of the International AIDS Society 2008, 11(Suppl 1):O5 (10 November 2008) [Abstract] [Full text] [PDF] Oral presentation
 O121 Drug interactions that really matter SH Khoo Journal of the International AIDS Society 2008, 11(Suppl 1):O6 (10 November 2008) [Abstract] [Full text] [PDF] Oral presentation
 O122 Prevalence of drug interactions between antiretroviral and co-administered drugs at the Moi teaching and referral hospital (Ampath), Eldoret, Kenya GK Kigen, S Kimaiyo, DJ Back, SE Gibbons, E Sang, IG Edwards, A Owen, SH Khoo Journal of the International AIDS Society 2008, 11(Suppl 1):O7 (10 November 2008) [Abstract] [Full text] [PDF] Oral presentation
 O123 To overdose or underdose? The question of Kaletra in children in the UK/Irish Collaborative HIV Paediatric Study (CHIPS) AS Walker, KL Boyd, K Doerholt, H Lyall, E Menson, K Butler, P Tookey, A Riordan, D Shingadia, A Judd, G Tudor-Williams, DM Gibb Journal of the International AIDS Society 2008, 11(Suppl 1):O8 (10 November 2008) [Abstract] [Full text] [PDF] Oral presentation
 O124 Efavirenz and rifampicin in the South African context: is there a need to dose increase efavirenz with concurrent rifampicin therapy? C Orrell, K Cohen, P Ive, I Sanne, R Wood Journal of the International AIDS Society 2008, 11(Suppl 1):O9 (10 November 2008) [Abstract] [Full text] [PDF] Oral presentation
 O125 Impact of efavirenz and nevirapine on pharmacokinetics of lopinavir/ritonavir as tablets and capsules in African patients C Kityo, AS Walker, F Lutwana, F Ssali, R Nalumenya, D Tumukunde, J Kawiya, P Munderi, A Reid, CF Gilks, DM Gibb, SH Khoo Journal of the International AIDS Society 2008, 11(Suppl 1):O10 (10 November 2008) [Abstract] [Full text] [PDF] Oral presentation
 O132 Secondline ART in the developing world J Hakim Journal of the International AIDS Society 2008, 11(Suppl 1):O11 (10 November 2008) [Abstract] [Full text] [PDF] Oral presentation
 O131 Where are we with National and International guidelines? E Katabira Journal of the International AIDS Society 2008, 11(Suppl 1):O12 (10 November 2008) [Abstract] [Full text] [PDF] Oral presentation
 O135 Seek and treat for optimal prevention of HIV/AIDS (STOP HIV/AIDS) JSG Montaner Journal of the International AIDS Society 2008, 11(Suppl 1):O13 (10 November 2008) [Abstract] [Full text] [PDF] Oral presentation
 O133 HIV/TB: when is it safe to start HAART? R Wood Journal of the International AIDS Society 2008, 11(Suppl 1):O14 (10 November 2008) [Abstract] [Full text] [PDF] Oral presentation
 O134 HIV disease management and challenges in Eastern Europe and Central Asia A Bobrik Journal of the International AIDS Society 2008, 11(Suppl 1):O15 (10 November 2008) [Abstract] [Full text] [PDF] Oral presentation
 O211 HIV and the brain: neuro-inflammation long-term, CNS control of HIV replication, brain disease in suppressed patients and differential penetration of drugs D Clifford Journal of the International AIDS Society 2008, 11(Suppl 1):O16 (10 November 2008) [Abstract] [Full text] [PDF] Oral presentation
 O212 Rate of change in CD4 counts in patients with stable HIV viremia AN Phillips, B Ledergerber, JR Bogner, K Lacombe, A Wiercinska-Drapalo, P Reiss, O Kirk, JD Lundgren, A Mocroft Journal of the International AIDS Society 2008, 11(Suppl 1):O17 (10 November 2008) [Abstract] [Full text] [PDF]
| |
|   |